Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SWKS vs MRNA✓SelectedUSD · MRNASWKS vs MRNA performance historyLatest closeAs of-3.82%11/16
Stock and ETF performance explorer

SWKS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-39.2%
MRNA return
-8.0%
Excess return
-31.2%
Maximum drawdown
-67.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-3.8%-3.6%-0.2%-3.6%
7D+4.4%-20.0%+24.4%+6.1%
30D+8.5%-1.3%+9.8%+8.3%
3M+24.2%+240.0%-215.7%+4.6%
6M+27.3%+339.0%-311.6%+0.5%
YTD+39.3%+630.0%-590.7%-3.5%
1Y+34.1%+769.1%-735.0%-11.0%
3Y+2.1%+181.2%-179.1%-21.0%
5Y-39.2%-8.1%-31.1%-48.4%
All-39.2%-8.0%-31.2%-48.4%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling